The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations.
The aim of this retrospective study was to determine the prevalence of lysosomal storage disorders (LSDs) in the Czech Republic. The data on cases diagnosed between 1975 and 2008 were collected and analyzed. The overall prevalence of LSDs in the Czech population (12.25 per 100,000) is comparable to that reported for the countries with well-established and advanced diagnostics of LSDs such as the Netherlands (14 per 100,000), Australia (12.9 per 100,000) and Italy (12.1 per 100,000). Relatively higher prevalence of LSDs was reported in the north of Portugal (25 per 100,000). Thirty-four different LSDs were diagnosed in a total of 478 individuals. Gaucher disease was the most frequent LSD with a birth prevalence of 1.13 per 100,000 births. The most frequent LSD groups were lipidoses, mucopolysaccharidoses, and neuronal ceroid lipofuscinoses, with combined prevalences of 5.0, 3.72, and 2.29 per 100,000 live births, respectively. Glycoproteinoses (0.57 per 100,000 live births), glycogenosis type II (0.37), and mucolipidoses (0.31) rarely occur in the Czech population, and a range of other LSDs have not been detected at all over the past three decades. Knowledge of the birth prevalence and carrier frequency of particular disorders is important in genetic counselling for calculation of the risk for the disorder in the other members of affected families. Earlier diagnosis of these disorders will permit timely intervention and may also result in lowering of the number of newborns with LSDs.
Poupetová
Helena
H
Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Ke Karlovu 2, 128 08, Prague 2, Czech Republic.
Ledvinová
Jana
J
Berná
Linda
L
Dvoráková
Lenka
L
Kozich
Viktor
V
Elleder
Milan
M
D001315:Australia / Q000453:epidemiology; D018153:Czech Republic / Q000453:epidemiology; D005260:Female; D005817:Genetic Counseling; D020022:Genetic Predisposition to Disease / Q000453:epidemiology; D006579:Heterozygote; D006801:Humans; D007231:Infant, Newborn; D007558:Italy / Q000453:epidemiology; D016464:Lysosomal Storage Diseases / Q000453:epidemiology* / Q000235:genetics*; D008297:Male; D009426:Netherlands / Q000453:epidemiology; D011174:Portugal / Q000453:epidemiology; D015995:Prevalence; D012189:Retrospective Studies